ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With...
                   
redorbit.com     May 16, 2008            

Posted on: Thursday, 15 May 2008, 21:00 CDT INDIANAPOLIS, May 15 /PRNewswire-FirstCall/ -- Lung cancer patients whose histology is factored into treatment decisions may fare better as a result, according to data from a pivotal non-small cell lung cancer (NSCLC) clinical trial. "The data presented... [read full story]                    


View all news articles about*:
Ambulatory America ASCO Body Cancer Cancers Care Eli Health Indiana Indianapolis Lilly Location Lung Medical North Oncology Patients Research States Therapy United
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Eli Lilly acquires SGX Pharmaceuticals

news-medical.net     1 hr ago          

Eli Lilly and Company has announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. (Public, NASDAQ:SGXP), a San Diego-based biotechnology company focused on drug discovery and development in the area of...                    

comments

                   

Lilly Announces Completion of SGX Acquisition

redorbit.com     5 hrs ago   3 related          

INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. , a San Diego-based biotechnology company focused on drug discovery...                    

comments

PDL Could Get $1.2B from BMS for Two Early Stage Antibodies

tmcnet.com     6 hrs ago   8 related          

710M for Elotuzumab After struggling through a year of shifting business strategies, PDL BioPharma Inc. signed an antibody deal with Bristol-Myers Squibb Co. that could be worth nearly $1.16 billion. The deal calls for New...                    

comments

                   

VioQuest Pharmaceuticals Announces Second Quarter 2008 Financial Results and Corporate Highlights

genengnews.com     6 hrs ago   48 related          

News source: Business Wire VioQuest Pharmaceuticals, Inc. today reported its financial results for the three- and six-month periods ended June 30, 2008, and provided an update on recent corporate activities. The Company's net...                    

comments